Fate Therapeutics FATE
NASDAQ FATE
$1.38 -0.23 (-14.33%)
As of: Nov 12, 2026 · 2:11 PM EST

Fate Therapeutics (FATE) Sales of Property, Plant and Equipment (2014 - 2025)

Updated

Fate Therapeutics (FATE) recorded Sales of Property, Plant and Equipment of $237,000 in Q4 2025.

Analysis

Fate Therapeutics (FATE) Sales of Property, Plant and Equipment (2014 - 2025) Analysis & Trends

For FY2025, Fate Therapeutics reported Sales of Property, Plant and Equipment of $362,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Fate Therapeutics 215.18 Mn 76.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 237,000.00
Sep 30, 2025 3,000.00
Mar 31, 2014 208,000.00
API Access

Fate Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=FATE&period=max&api_key=YOUR_API_KEY